Badger Meter (BMI) Jumps 7.67% on February 03

Equities Staff |

Badger Meter (BMI) was among the biggest gainers on the Russell 2000 for Wednesday February 03 as the stock popped 7.67% to $59.69, representing a gain of $4.25 per share. Some 92,290 shares traded hands on 1,027 trades, compared with an average daily volume of 86,064 shares out of a total float of 14.51 million. The stock opened at $58.40 and traded with an intraday range of $59.72 to $57.08.

After today's gains, Badger Meter reached a market cap of $866.28 million. Badger Meter has had a trading range between $65.87 and $51.63 over the last year, and it had a 50-day SMA of $57.74 and a 200-day SMA of $59.91.

The stock has a P/E Ratio of 29.8.

Badger Meter Inc is a manufacturer and marketer of products incorporating liquid flow measurement and control technologies. It serves water utilities, municipalities and commercial & industrial customers.

Badger Meter is based out of Milwaukee, WI and has some 1,431 employees. Its CEO is Richard A. Meeusen.

For a complete fundamental analysis analysis of Badger Meter, check out Equities.com’s Stock Valuation Analysis report for BMI. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

8tracks

Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.